4//SEC Filing
Clarus Lifesciences III, L.P. 4
Accession 0001567619-18-003533
CIK 0001656634other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:20 PM ET
Size
15.2 KB
Accession
0001567619-18-003533
Insider Transaction Report
Form 4
Clarus Lifesciences III, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2018-09-28$15.00/sh+333,333$4,999,995→ 333,333 total - Conversion
Common Stock
2018-10-02+2,234,112→ 2,567,445 total - Conversion
Series A Convertible Preferred Stock
2018-10-02−1,565,216→ 0 total→ Common Stock (1,565,216 underlying) - Conversion
Series B Convertible Preferred Stock
2018-10-02−668,896→ 0 total→ Common Stock (668,896 underlying)
Footnotes (3)
- [F1]Clarus Ventures III GP, L.P. ("GPLP"), as the sole GP of the Reporting Person, may be deemed to beneficially own certain shares held by the Reporting Person. The GPLP disclaims beneficial ownership of all shares held by the Reporting Person in which the GPLP does not have pecuniary interest. Clarus Ventures III, LLC ("GPLLC"), as the sole GP of the GPLP, may be deemed to beneficially own certain of the shares held by the Reporting Person. The GPLLC disclaims beneficial ownership of all shares held by the Reporting Person in which it does not have pecuniary interest. Each of Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, Scott Requadt and Kurt Wheeler, as managing directors of the GPLLC, may be deemed to beneficially own certain shares held by the Reporting Person. Each of Messrs. Galakatos, Henner, Liptak, Simon, Requadt and Wheeler disclaims beneficial ownership of all shares held of record by the Reporting Person in which he does not have pecuniary interest.
- [F2]The Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F3]The Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Documents
Issuer
Gritstone Oncology, Inc.
CIK 0001656634
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001597143
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:20 PM ET
- Size
- 15.2 KB